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Analysis of the brain mural cell 
transcriptome
Liqun He1, Michael Vanlandewijck1,2, Elisabeth Raschperger1,2, Maarja Andaloussi Mäe1, 
Bongnam Jung1, Thibaud Lebouvier1, Koji Ando1, Jennifer Hofmann1, Annika Keller3 & 
Christer Betsholtz1,2
Pericytes, the mural cells of blood microvessels, regulate microvascular development and function and 
have been implicated in many brain diseases. However, due to a paucity of defining markers, pericyte 
identification and functional characterization remain ambiguous and data interpretation problematic. 
In mice carrying two transgenic reporters, Pdgfrb-eGFP and NG2-DsRed, we found that double-positive 
cells were vascular mural cells, while the single reporters marked additional, but non-overlapping, 
neuroglial cells. Double-positive cells were isolated by fluorescence-activated cell sorting (FACS) and 
analyzed by RNA sequencing. To reveal defining patterns of mural cell transcripts, we compared the 
RNA sequencing data with data from four previously published studies. The meta-analysis provided a 
conservative catalogue of 260 brain mural cell-enriched gene transcripts. We validated pericyte-specific 
expression of two novel markers, vitronectin (Vtn) and interferon-induced transmembrane protein 
1 (Ifitm1), using fluorescent in situ hybridization and immunohistochemistry. We further analyzed 
signaling pathways and interaction networks of the pericyte-enriched genes in silico. This work 
provides novel insight into the molecular composition of brain mural cells. The reported gene catalogue 
facilitates identification of brain pericytes by providing numerous new candidate marker genes and is a 
rich source for new hypotheses for future studies of brain mural cell physiology and pathophysiology.
All vertebrate blood vessels contain two principal cell types, endothelial cells (EC) and mural cells. The mural cells 
of larger blood vessels, vascular smooth muscle cells (VSMC), are contractile and regulate vascular tone and blood 
flow. Less is known about the microvascular mural cells, a.k.a. pericytes (PC)1–3, but their importance in vascular 
development, maintenance and pathology, in the central nervous system (CNS) in particular, is increasingly dis-
cussed. Mouse studies demonstrate that PC are necessary for vascular morphogenesis and EC quiescence in the 
brain and retina4–8 and for the formation of an intact blood-brain barrier (BBB)9,10. In addition, PC are implicated 
in regulation of cerebral blood flow11,12, although the identity of the contributing mural cell remains a topic of 
debate13. PC also regulate the localization of certain proteins to astrocyte end feet9. However, the PC-derived sig-
nals involved in these processes are unknown. PC have also been implicated in the pathogenesis of several human 
brain diseases14. For example, PC death or damage has been observed in diabetic retinopathy15,16, brain ischemia 
and stroke11, traumatic brain injury17–20, septic encephalopathy21,22, and in genetic brain diseases, including pri-
mary familial brain calcification (PFBC)23,24, early-adult onset dementia25 and cerebral proliferative glomeruloid 
vasculopathy26. Reduced or altered PC have been reported in Alzheimer’s disease (AD)27–32, mild dementia33 
and amyotrophic lateral sclerosis (ALS)34,35. The PC phenotype may be secondary in many of these conditions. 
An active involvement in disease pathogenesis has been suggested in mice expressing the AD-risk allele APOE4, 
where disruption of BBB integrity depends on MMP9 expression by PC36. Direct involvement of PC in PFBC 
pathogenesis is also plausible, since disease-causing mutations have been reported in the platelet-derived growth 
factor B (PDGFB) and PDGF receptor-beta (PDGFRB) genes23,37, which have known roles in PC biology38.
The notions that PC are abundant in the CNS and play important roles in cerebrovascular biology have stimu-
lated efforts to molecularly characterize these cells using different profiling methods. However, PC are difficult to 
separate from EC, and therefore, mostly indirect methods have been used to deduce the PC transcriptome9,39,40. 
Some information is also available through brain single cell-sequencing projects41. We reasoned that by compar-
ing published data with direct profiling of isolated brain mural cells, we would derive significantly deeper and 
more authentic information on the brain mural cell transcriptome. To this end, we generated a double transgenic 
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mouse by crossing mice expressing enhanced green fluorescent protein (eGFP) under control of the Pdgfrb pro-
moter (Gensat.org) with mice expressing DsRed under control of the NG2 promoter42. The double reporter mice 
(Pdgfrb-eGFP/NG2-DsRed mice) expressed both reporters only in mural cells in the brain, whereas the single 
reporters were also expressed in other neuroglial cells in non-overlapping patterns. This allowed us to isolate brain 
mural cells by FACS and analyze the cells with high throughput next-generation RNA sequencing (RNA-seq).
We combined the results from the four published studies9,39–41 with our newly produced RNA-seq data into a 
meta-analysis with the aim of constructing a catalogue of brain mural cell-enriched genes. The resulting gene cata-
logue provides direct insights into the unique molecular composition, signaling pathways and protein interaction 
networks within vascular mural cells of the brain.
Results
Specific labeling of mural cells in Pdgfrb-eGFP/NG2-DsRed mice. We crossbred NG2-DsRed mice42 
with Pdgfrb-eGFP mice (Gensat.org. Line name: Tg(Pdgfrb-eGFP)JN169Gsat/Mmucd) with the assumption that 
simultaneous expression of the two markers in the same cells would allow specific identification and enrich-
ment of PC. Pdgfrb and NG2 are two commonly used markers for mural cells, neither of which are completely 
PC-specific. Their non-mural cell expression in the brain appeared non-overlapping, however, (Fig. 1A,D) with 
abundant Pdgfrb-eGFP expression noticeable in the subventricular zone and NG2-DsRed expression scattered 
throughout the brain in cells that likely correspond to oligodendrocyte progenitors (OPC)43. Cells with concur-
rent expression of Pdgfrb-eGFP and NG2-DsRed were invariably associated with the blood vessel endothelium, 
and had the expected location, density, distribution and morphology of vascular mural cells (Fig. 1A). To char-
acterize these cells in more detail, we immuno-stained brain sections from Pdgfrb-eGFP mice using antibodies 
against alpha-smooth muscle actin (α -SMA) or CD31 (PECAM1) (Fig. 1B). This revealed that Pdgfrb-eGFP-
positive cells occupied all types of blood vessels, i.e. arteries, veins and capillaries, as defined by their morphology 
and diameter2. In arteries, Pdgfrb-eGFP-positive cells co-labeled with α -SMA and displayed the typical morphol-
ogy of VSMC, suggesting that they represent arterial and arteriolar VSMC (Fig. 1B, inserts). Pdgfrb-eGFP-positive 
cells lining smaller veins and capillaries expressed very low, or undetectable, levels of α -SMA, as revealed by 
antibody staining, and displayed the characteristic morphology of venous VSMC and PC, respectively (Fig. 1B). 
In separate stainings, we confirmed that the Pdgfrb-eGFP-positive cells were labeled with antibodies against 
PDGFRβ (Fig. 1C) and CD13 (Fig. 1E), supporting their mural cell identity, and that the Pdgfrb-eGFP-positive 
cells surrounding capillaries were also positive for NG2-DsRed (Fig. 1D). Finally, we explored the overlap between 
Pdgfrb-eGFP and NG2-DsRed expression in different types of vessels in different parts of the CNS, including the 
retina (Fig. 1F and data not shown). Whereas we found a complete overlap between Pdgfrb-eGFP and NG2-DsRed 
expression in capillary PC, and little if any variation in marker expression between individual PC, the expression 
in arteriolar and venular mural cells was more heterogeneous. In particular, we noticed that some strongly Pdgfrb-
eGFP-positive cells in arteriolar and venular walls had weak or undetectable NG2-DsRed expression (Fig. 1F, 
white arrows). The location of these cells did not display any particular bias, and we therefore do not know if this 
heterogeneity reflects the existence of different subtypes of mural cells, or stochastic dynamic fluctuations of the 
marker expression. However, we conclude, based on extensive immunohistological characterization, that double 
Pdgfrb-eGFP/NG2-DsRed positive cells comprise both capillary PC and arteriolar and venular mural cells and 
likely do not represent other cell types in the brain.
RNA-seq of brain mural cells and microvascular fragments. We sorted double positive cells from 
the brain of Pdgfrb-eGFP/NG2-DsRed transgenic mice using FACS (Fig. 2). RNA was extracted and sequenced 
by next-generation sequencing. We also determined the transcriptome of brain microvascular fragments (con-
taining both endothelial cells and mural cells) isolated by mechanical tissue disintegration, collagenase digestion 
and immune-panning using anti-CD31 antibodies coupled to magnetic beads9. The RNA-seq data was aligned to 
the mouse reference genome and sequence counts were summarized. The results showed that mRNA transcripts 
representing 856 different genes were enriched more than two-fold in FACS isolated Pdgfrb-eGFP/NG2-DsRed 
double positive cells compared with whole microvascular fragments (False Discovery Rate < 0.05) (Supplemental 
Table S1).
We examined the expression levels and fold enrichment of a set of known PC markers (Table 1) in 
Pdgfrb-eGFP/NG2-DsRed double positive cells compared with microvascular fragments. Based on the FPKM 
values (Fragments Per Kilobase Of Exon Per Million Fragments Mapped), these markers ranged in their expres-
sion from high (Rgs5 FPKM > 1000), to medium/low abundance (Anpep, Des, Dlk1 FPKM < 100 (Table 1). When 
comparing the fold enrichment for the known PC markers between sorted cells and vascular fragments, we found 
that the average enrichment was approximately 9-fold (Table 1), suggesting that approximately one out of nine 
cells in the microvascular fragments represent PC or other mural cells.
Identification of brain mural cell-enriched gene transcripts. We compared the RNA-seq results with 
the results from four previously published studies in which mural cell transcriptome data has been reported 
(Table 2). These studies include two microarray analyses of microvascular fragments isolated from PC-deficient 
mouse mutants, which identified 453 and 135 significantly down-regulated gene transcripts, respectively, in the 
PC-deficient states9,39. The down-regulated transcripts would be expected to include PC-enriched transcripts but 
also EC transcripts positively regulated by PC. A third study also used an indirect approach, in which EC iso-
lated from Tie2-GFP transgenic mice were compared before and after panning using anti-PDGFRβ antibodies to 
remove contaminating PC40. This procedure revealed 175 genes as putatively brain PC-enriched and 1631 genes 
as brain EC-enriched. The fourth study, a single cell RNA-seq of brain tissue41, revealed 155 genes to be predom-
inantly enriched in brain vascular mural cells. A comparison between the five studies (the present and previous 
four) is provided in Table 2. Mentioned gene lists are listed in Supplementary Table S1.
www.nature.com/scientificreports/
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Since PC and EC are embedded within a common microvascular basement membrane (BM), these cells 
are difficult to separate and isolate without any reciprocal contamination. In order to subtract contaminating 
EC-specific transcripts from the 5 mural cell datasets (Table 2), we made use of the brain EC-enriched gene list 
(1631 genes) reported by Daneman et al.40. Using this approach, the degree of contamination of EC-enriched 
transcripts in the 5 datasets ranged from 6% to 27% (Table 2).
Integration of five different datasets to reveal a brain mural cell transcriptome. A comparison 
between the results obtained from the five different approaches to identify brain mural cell-enriched transcripts is 
illustrated in a Venn diagram (Fig. 3). A surprisingly limited overlap was noticed, and, moreover, each approach 
identified a substantial number of mural cell-enriched genes not supported by the other datasets. Only three 
transcripts (myosin light polypeptide 9 regulatory (Myl9), myosin light polypeptide kinase (Mylk), solute carrier 
Figure 1. Specific labeling of central nervous mural cells in Pdgfrb-eGFP/NG2-DsRed mice. (A) Expression 
pattern of Pdgfrb-eGFP and NG2-DsRed in cerebrum of Pdgfrb-eGFP/NG2-DsRed mice. In the lower panels, 
cells lining capillaries and with concurrent expression of both signals are pericytes (PC). The scale bars in the top 
and lower panels are 100 μ m and 50 μ m, respectively. (B) Pdgfrb-eGFP positive cells line blood vessels visualized 
by CD31 staining (in white) in the cerebrum of Pdgfrb-eGFP mice. Some of eGFP expressing cells express also 
alpha-smooth muscle actin (α -SMA, in red). The white arrows and arrowhead in insert point to the PC in the 
capillaries and PC/VSMC in the arteriole, respectively. Yellow arrows point to the vein covered by eGFP positive 
cells. The scale bars in top and lower panels are 50 μ m and 10 μ m, respectively. (C) Pdgfrb-eGFP positive cells in 
the cerebral cortex of Pdgfrb-eGFP mouse are expressing PDGFRβ (in red). The scale bar is 50 μ m. (D) Pdgfrb-
eGFP and NG2-DsRed expression in cerebral capillaries of Pdgfrb-eGFP/NG2-DsRed mice. The Pdgfrb-eGFP-
positive cells surrounding capillaries are also positive for NG2-DsRed. The scale bar is 30 μ m. (E) Pdgfrb-eGFP 
expressing cells are positive for PC marker CD13 (in red). E’ shows a higher magnification image. The scale 
bars in E and E’ are 100 μ m and 10 μ m, respectively. (F) Expression pattern of Pdgfrb-eGFP and NG2-DsRed in 
the retina of Pdgfrb-eGFP/NG2-DsRed mice. White arrows indicate Pdgfrb-eGFP-positive cells with weak or 
undetectable NG2-DsRed expression. The scale bars in left panels and the right enlarged panels are 50 μ m and 
10 μ m, respectively.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:35108 | DOI: 10.1038/srep35108
family 19 member 1 (Slc19a1) were commonly identified by the five studies. Of these three genes, Mylk and Myl9 
are involved in the signaling pathways regulating VSMC contraction, and they are usually co-regulated in tissue 
transcript profiling experiments, as exemplified in cancer44. Brain single cell RNA sequencing showed that Mylk and 
Myl9 are both abundantly expressed in VSMC41. Slc19a1 is a folate transporter, and while it is supposed to be broadly 
expressed (with high levels in e.g. liver and lung)45, its role in brain mural cells has not been explored previously to 
our knowledge. Interestingly, the common identification of Myl9, Mylk and Slc19a1 in the five studies could not be 
explained by high mRNA abundance, which ranged between FPKM≈ 600 (Myl9) to FPKM≈ 100 (Slc19a1).
Figure 2. FACS of mural cells from brains of Pdgfrb-eGFP/NG2-DsRed mice. Dot blots showing the intensity 
of eGFP and DsRed channel of analyzed cells from (A) a negative control (C57BL6) and (B) Pdgfrb-eGFP/
NG2-DsRed mice. The sorted, double-positive cell population is indicated by the rectangle in the upper right 
quadrant.
Ensembl ID Symbol Microvasculature (FPKMa) Mural cell (FPKMa)
Enrichment foldb (Mural cell/ 
Microvasculature)
ENSMUSG00000035783 Acta2 58,2 726,2 12,5
ENSMUSG00000030247 Kcnj8 12,6 136,7 10,9
ENSMUSG00000024620 Pdgfrb 45,4 445,2 9,8
ENSMUSG00000056481 Cd248 35,9 341,2 9,5
ENSMUSG00000039062 Anpep 9,2 83,8 9,1
ENSMUSG00000026208 Des 8,9 81,0 9,1
ENSMUSG00000040856 Dlk1 7,2 64,7 9,0
ENSMUSG00000032368 Zic1 47,3 376,8 8,0
ENSMUSG00000030249 Abcc9 35,7 282,3 7,9
ENSMUSG00000026678 Rgs5 176,5 1302,3 7,4
ENSMUSG00000032911 Cspg4 39,7 257,3 6,5
Table 1.  Gene expression of known pericyte markers in microvasculature and pericyte samples. Listed are 
RNA-seq expression values for the known pericyte markers. aThe expression quantification is given by FPKM 
(Fragments Per Kilobase Of Exon Per Million Fragments Mapped). bThe enrichment fold shows the ratio of 
FPKM values between PC and microvasculature samples.
 Experimental model Age
# of identified 
mural cell genes
# of identified mural cell genes after 
removal of endothelial genes
Endothelial 
genes (%) Reference
1 Pdgfbret/ret mutant versus control 7–10 months 453 354 21,85% Armulik et al.9
2 Pdgfb/Pdgfrb mutant versus control E17.5 135 99 26,67% Bondjers et al.39
3 Vasculature versus endothelium P60-70 175 164 6,29% Daneman et al.40
4 Single cell analysis of brain mural cells P21-31 155 142 8,39% Zeisel et al.41
5 Pdgfrb-eGFP and NG2-DsRed double positive mural cells P6 856 788 7,94% current study
Table 2.  Some details of five studies on the brain mural cells transcriptome. Listed are details of four 
previously published studies and our current study. The following details are listed: the experimental model, 
the age of the mice, the number of total identified mural genes, the percentage of contaminated EC genes, the 
number of mural genes after removal of EC genes and references.
www.nature.com/scientificreports/
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In total, 1180 different genes were identified as enriched in mural cells by at least one study. For our further 
analyses, we focused on genes that were identified by at least two studies, hence those that could be regarded as 
cross-validated and, therefore, relatively reliable. By this criterion, 260 genes were selected to be included into a 
brain mural cell-enriched gene catalogue (Supplementary Table S2).
These 260 genes include all known PC markers, including Pdgfrb, Cspg4, Abcc9, Kcnj8, Rgs5, Notch3, Zic1, 
Dlk1, Cd248, Des, Acta2 and Anpep. We therefore conclude that this catalogue is valuable resource for the further 
identification of mural cell markers, and genes that are functionally important for the biology of brain vascular 
mural cells, including PC.
In order to visualize the results from different studies and their comparisons, we created a website in which the 
brain mural cell transcriptome can be explored (http://betsholtzlab.org/brainMural/genes.html).
Novel brain mural cell markers verified by in situ hybridization. Although we argue that the full 
260-gene catalogue provides a conservative and reliable source of marker transcripts that distinguish mural cells 
including PC from EC in the brain, we chose two novel candidate markers for brain PC for validation by fluo-
rescent in situ hybridization (ISH): Vitronectin (Vtn) and interferon induced transmembrane protein 1 (Ifitm1). 
These were selected based on their specificity for mural cells and mRNA abundance in the RNA-seq dataset 
from the present study. Both showed strong specificity; > 9 fold enrichment for Vtn and > 5 fold enrichment for 
Ifitm1 in the FACS sorted Pdgfrb-eGFP/NG2-DsRed double positive cells compared with microvascular frag-
ments. However, their abundance differed markedly; Vtn FPKM = 885; Ifitm1 FPKM = 49. Accordingly, ISH 
detected Vtn mRNA at high abundance in PC surrounding capillaries, with mRNA detectable both in the cell 
body and PC processes (Fig. 4A, arrowhead). In these experiments the PC identity of single cells was determined 
by co-labeling for Pdgfrb (positive) and CD31/Pecam1 (negative) mRNA. A specific Vtn signal was also detected 
in mural cells surrounding blood vessels with a wider diameter (arterioles or veins) but the signal in these cells 
was lower than in capillary PC (Fig. 4A, arrow). Immunohistochemical staining of brain slices using anti-VTN 
antibodies confirmed the ISH result (Fig. 4C), in that it co-localized with PC cell bodies and cellular processes. In 
accordance with the lower FPKM for Vtn in the RNA-seq analysis, Ifitm1 ISH displayed a weak but specific signal 
in PC (Fig. 4B).
Subcellular location of the brain mural cell-enriched genes. We mapped the 260 brain mural 
cell-enriched genes into their cellular locations using the CellWhere database46 (Table 3). This classification 
showed that 49 genes (19%) encode extracellular proteins, 98 genes (38%) encode membrane proteins, 67 genes 
(25%) encode cytoplasmic proteins, 30 genes (12%) encode nuclear proteins and 16 genes (6%) encode pro-
teins with unclear/ambiguous cellular location. The proportion of the genes that encode extracellular and plasma 
membrane proteins is statistically significantly higher (Hypergeometric test) in the 260 mural cell-enriched (2–3 
fold) than in any randomly selected gene list.
Enriched pathway and interaction networks among the pericyte-enriched gene catalogue. We 
further mapped the brain mural cell enriched gene catalogue of 260 genes to the Kyoto Encyclopedia of Genes 
and Genomes (KEGG) pathways and identified a number of pathways that were significantly enriched (Table 4). 
Whereas most of these appear to reflect functions related to cell contraction and adhesion, perhaps expected from 
any mural cell population, the pathway Neuroactive ligand-receptor interaction may reflect some specific proper-
ties of brain mural cells and their role in the neurovascular unit. Transcriptional profiling of mural cells isolated 
from other organs than brain may shed light on this issue.
The Human Protein Reference Database (HPRD; www.hprd.org) contains manually curated protein–pro-
tein interaction data from published literature. To obtain information on protein-protein interactions within 
Figure 3. Venn diagram showing the overlap of identified mural cell genes between different datasets. The 
studies where these datasets have been reported are listed in Table 2.
www.nature.com/scientificreports/
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the 260-list, we mapped the corresponding human orthologues and extracted their protein-protein interaction 
information. This revealed over 20 interaction pairs and several interaction groups (Fig. 5). Among these, some 
proteins belong to the same family, such as GUCY1A2 (guanylate cyclase 1, soluble, alpha 2) and GUCY1B3 (gua-
nylate cyclase 1, soluble, beta 3), or form ligand-receptor pairs, such as IGF2 (insulin-like growth factor 2) and 
IGF2R (insulin-like growth factor 2 receptor). Additionally, proteins with known functional connections were 
detected, such as KCNJ8 and ABCC9.
Figure 4. Validation of novel brain pericyte markers by in situ hybridization and immunohistochemistry. 
RNA in situ hybridization of 2-month old C57BL6 mouse cerebral cortex. (A) Vitronectin (Vtn, in red) is 
expressed in PC, identified by Pdgfrb expression (in green). While Pdgfrb expression is restricted to the cell 
body, Vtn can be found also in PC processes. Arrowhead points to a PC, arrow points to a vascular smooth 
muscle cell. In magnified inset is seen an overlap of Pdgfrb and Vtn expression in a PC. Cell nuclei are 
visualized by DAPI (in blue) and EC are visualized by Pecam1 expression (in white). (B) Interferon induced 
transmembrane protein 1 (Ifitm1, in red) is expressed in PC, identified by Pdgfrb expression (in green). In 
inserts, cell nuclei are encircled with dotted lines. Arrow points to a PC nucleus, arrowhead points to an EC 
nucleus. Cell nuclei are visualized by DAPI (in blue) and EC are visualized by Pecam1 expression (in white).  
(C) Immunohistochemical detection of vitronectin (in red) in PC (in green, CD13). The higher magnification 
image (C’) shows a strong expression of vitronectin in PC cell body and processes. The scale bars in top and 
lower panels are 20 μ m (A,B), 50 μ m (C) and 10 μ m (A,B and C’), respectively.
www.nature.com/scientificreports/
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For soluble guanylate cyclases (GC), alpha and beta subunits interact to form the active enzyme. GC play a key 
cardiovascular role as targets of nitric oxide (NO), catalyzing the production of the intracellular signaling mole-
cule cyclic guanosine monophosphate (cGMP)47. Homozygous Gucy1b3 null mice die soon after birth, displaying 
gastrointestinal obstruction and hypertension phenotypes48. Soluble GC have been demonstrated in rat skeletal 
muscle PC49, but its enriched expression in brain PC have not been reported previously. It is possible that GUCY 
has a role in regulation of brain vessel diameter. However, glutamate evoked capillary dilation mediated by PC 
requires nitric oxide but is independent of GC11.
SLC9A3R1 (solute carrier family 9, isoform A3, regulatory factor 1, also known as EBP50, NHERF) is a Na 
(+ )/H(+ ) exchanger regulatory factor. SLC9A3R1 binds PDGFRβ and potentiates its activity in vitro50. 
SLC9A3R1 interacts with SLCO3A1 (solute carrier family 21 member 11, namely OATP-D) through its PDZ 
domain51 and binds to PTH1R (parathyroid hormone 1 receptor)52. The physiological relevance of these inter-
actions is unclear, but may engage in signaling and molecular trafficking between PC and neighboring cells. 
Importantly, their functional roles in PC in vivo await further investigation.
KCNJ8 and ABCC9 jointly form an ATP/ADP-binding potassium channel53. We previously identified these 
two genes as brain PC markers in mouse39. Recently, mutations in any of the two genes were linked to Cantú 
Syndrome54,55, a genetic disease that manifests with multiple phenotypic abnormalities, including excess of hair 
growth, skeletal abnormalities and various cardiovascular problems56. The specific expression of KCNJ8 and 
ABCC9 in vascular mural cells, in particular brain PC, may suggest a role for these cells in the pathogenesis of 
Cantú Syndrome.
Discussion
While vascular mural cells are undoubtedly heterogeneous, ranging from typical VSMC to typical PC, the defi-
nition of PC remains ambiguous. Several functions have been tied to PC, including regulation of developmental 
blood vessel stabilization4,5, blood flow11, vascular barrier formation and integrity9,10 and leukocyte trafficking57,58. 
PC have also been assigned a stem cells function in tissue repair and fibrosis59–65. Usually, these functions have 
been studied in single or few organs, and it is unclear whether they are general properties of PC. It is also not 
resolved whether PC constitute a homogenous cell population within each organ, or if there are subtypes with 
different functions. The latter has been suggested in the context of spinal cord injury66. Moreover, the identity of 
the type of mural cells that regulate blood-flow in the CNS remains debated67,68. Mural cells have several develop-
mental origins2, but whether this translates into molecular or functional differences is not known.
Only a handful of PC markers are known, all of which are dynamic in their expression, and none of them is 
specific to PC. Adding further to the difficulties, anatomical location and morphological hallmarks are ambiguous 
criteria for PC identification, since several other cell types are tightly apposed to EC. The original defining char-
acteristic of PC was that they are embedded within the microvascular BM. While this definition is still applied, it 
is problematic. Transmission electron microscopy (TEM) is usually required to reveal the BM-embedded nature 
of PC, but TEM is unsuited for quantitative or high throughput studies or in situations where the BM is immature 
or abnormal. A seemingly vascular BM-embedded cell might be sandwiched between neighboring vascular and 
non-vascular BMs. This may be the case for cells located within the Virshow-Robin space. For practical reasons, 
current PC identification therefore relies on a combination of morphological criteria and marker expression2. 
Commonly used markers include Pdgfrb4, Cspg4 (NG2)69, Des (desmin)5 and Anpep (CD13)2, but several other 
markers have also been described, including Rgs570, Abcc9 (Sur2)39, Kcnj8 (Kir6.1)39, Dlk139, and Acta271.
Here, we applied a double transgenic reporter approach in order to isolate and characterize the transcrip-
tome of brain vascular mural cells. PDGFRβ and NG2 are both commonly used markers for the identification 
of PC by immunohistochemistry, and NG2-DsRed mice have previously been used to image PC42. As mentioned 
Cellular location # of genes Gene symbols
Extracellular 49
Adamts15 Adamts16 Adamts8 Arhgap42 Aspn Bgn Bmp5 C1qtnf2 C1qtnf7 C1s Ccdc80 Chn1 Col1a2 
Col3a1 Col5a2 Crispld2 Daam2 Efemp2 Egflam Emilin1 F2r Fstl1 Gpc6 Hspa12a Igf2 Il34 Lama2 Lgals1 
Lipg Ltbp3 Nid1 Nodal Nov Ntn1 Ogn Pcolce Pdgfa Pgf Pla1a Prelp Ptn Pxdn Rarres2 Serping1 Serpini1 
Sfrp2 Tnxb Vtn Wnt5b
Membrane 98
Abcc9 Ace2 Adcy6 Amigo2 Ano1 Ano4 Aoc3 Art3 Atp13a5 Atp1a2 Atp1b2 Atp2a3 Axl Bmpr1a Cacna1h 
Cadm4 Cap2 Cd248 Cdh11 Cpm Cspg4 Dlk1 Dmd Ednra Enpep Eps8 Evc Fap Fgfr3 Gfra2 Ggt1 Glrb 
Gpr20 Gpr30 Gprc5b Gpx8 Grm3 Higd1b Ifitm1 Igf2r Itga7 Itga8 Jam3 Kcne4 Kcnj8 Kcnmb1 Kirrel 
Lhfp Lin7a Marveld1 Mboat2 Mcam Mrvi1 Naalad2 Notch3 Npy1r Olfr558 Olfr78 P2rx1 P2ry14 Pcdh18 
Pde3a Pdgfrb Pla2r1 Plekha2 Plxdc1 Plxdc2 Plxnb1 Prkar1b Ptger3 Pth1r Rasl12 Rftn2 Ror1 Rrad S1pr3 
Samd4 Scn2b Sdc2 Sema6d Sgca Sh2d3c Slc12a2 Slc16a12 Slc19a1 Slc30a10 Slc38a11 Slc6a20a Slc7a2 
Slc9a3r1 Slco3a1 Steap4 Susd2 Sytl2 Tnfrsf21 Trpc1 Vasn Vstm4
Cytoplasm 67
Acta2 Adap2 Adrbk2 Aif1l Ankrd6 Arhgap10 Arhgef25 Cald1 Casq2 Cnn1 Cryab Ctnna3 Dact1 Dbndd2 
Ddit4l Dennd2a Des Dgkb Dtx3 Fads3 Fam101a Fam20a Farp1 Filip1l Flna Frk Gucy1a2 Gucy1a3 
Gucy1b3 Inpp4b Irs1 Lmcd1 Lmod1 Myh11 Myl9 Mylk Myom1 Ndrg2 Nts Palld Parva Pde1a Pde5a 
Pde8b Pdlim1 Pdlim3 Pid1 Pitpnc1 Plce1 Plcl1 Ppp1r14a Ptpn9 Rbms3 Rcn3 Rerg Rgs4 Rgs5 Sept11 
Sept8 Stk39 Stmn2 Tagln Tgfb3 Tpm1 Tpm2 Uchl1 Wtip
Nucleus 30 Alx3 Arvcf Ccnd2 Ctdspl Etv1 Foxd1 Foxs1 Hey2 Heyl Hic1 Hspa2 Kctd1 Lbh Mustn1 Myocd Nr2f1 Nr2f2 Nrip2 Pawr Prickle2 Prrx1 Rasl11a Rgs7bp Runx1t1 Tbx15 Tbx18 Tbx2 Uba2 Vgll3 Zic1
Unclear 16 1110059G02Rik 1500009L16Rik 6330403L08Rik Arhgef17 AW011738 Fam107b Gm13889 Itga10 Kctd15 Klhl23 Mn1 Rbpms2 Samd5 St5 Susd5 Tbc1d2b
Table 3.  Subcellular location of the brain mural cell-enriched genes. The identified 260 brain mural cell-
enriched genes are classified into subcellular locations. The gene symbols and the total number of genes in each 
category are listed.
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before, neither PDGFRβ nor NG2 are specific for vascular mural cells; PDGFRβ is also expressed by fibroblasts 
that are located in meninges and around larger blood vessels in the CNS72. We found Pdgfrb-eGFP expressed in 
neuronal cells in periventricular areas and Cspg4/NG2 by OPCs as expected, in addition to mural cells. Thus, 
the use of any single marker for FACS results in substantial heterogeneity, however, the double reporter was 
specific for mural cells. PC were uniformly strongly double positive for Pdgfrb-eGFP and NG2-DsRed, whereas 
VSMC labeling was heterogenous, with a proportion of the cells expressing little to no levels of NG2-DsRed. It 
is therefore possible that certain subtypes or sub-phenotypes of VSMC are not represented in our dataset. The 
double labeling approach for specific PC identification in brain was recently demonstrated using Pdgfrb-Cre and 
NG2-Cre-mediated reporter activation73, which provided a view of brain PC morphology and distribution that 
matches our data using Pdgfrb-eGFP;NG2-DsRed mice.
Previous studies have reported on mouse mural cell transcriptomes in vivo, each utilizing different approaches 
to achieve cell type specificity and different transcriptional profiling approaches9,39–41. This work includes two of 
our previously published microarray studies on mouse mutants (Pdgfb−/−, Pdgfrb−/−, Pdgfbret/ret and others) that 
genetically lack or have severely reduced PC numbers9,39, in which down-regulated transcripts in brain microves-
sels were considered candidate PC markers. A similar indirect approach was taken using brain EC isolates 
depleted from contaminating PC using anti-PDGFRβ antibodies40. A recent study provided preliminary insight 
into the mouse brain mural cell transcriptome through single cell RNA-seq41. It is reasonable to consider that each 
of these studies have their own advantages and limitations, especially with regard to contaminating cell types, 
but also considering the profiling methodology and depth of analysis. As listed in Table 2, potential PC-enriched 
genes were identified as down-regulated genes in the PC-deficient mice9,39. Expectedly, these two gene lists also 
include EC genes that are down-regulated secondary to PC deficiency, which likely explains a higher percentage 
of EC gene contaminations (22–27%) in those studies as compared with the other two studies (6–8%)40,41. For 
most of these studies it is important to consider that the data does not differentiate between PC and VSMC. The 
exception is the single cell RNA-seq study41, which provides preliminary insight into differences between PC and 
VSMC. However, due to the limitation in the number of presumptive VSMC (n= 62) and PC (n= 21) identified, 
the available sequence information is incomplete and noisy, duplicated word.
When comparing the results from all five mentioned studies9,39–41, a surprisingly limited overlap among 
mural cell-specific genes was observed. This may be explained by different development stages, physiological 
Pathway name p value # of gene Gene symbols
Focal adhesion 2,72E-10 17 Ccnd2 Col1a2 Col3a1 Col5a2 Flna Itga10 Itga7 Itga8 Lama2 Myl9 Mylk Parva Pdgfa Pdgfrb Pgf Tnxb Vtn
Vascular smooth muscle contraction 2,10E-09 13 Acta2 Adcy6 Cald1 Ednra Gucy1a2 Gucy1a3 Gucy1b3 Kcnmb1 Mrvi1 Myh11 Myl9 Mylk Ppp1r14a
Dilated cardiomyopathy 4,00E-09 11 Adcy6 Des Dmd Itga10 Itga7 Itga8 Lama2 Sgca Tgfb3 Tpm1 Tpm2
ECM-receptor interaction 3,28E-08 10 Col1a2 Col3a1 Col5a2 Itga10 Itga7 Itga8 Lama2 Sdc2 Tnxb Vtn
Calcium signaling pathway 7,42E-06 11 Atp2a3 Cacna1h Ednra F2r Mylk P2rx1 Pde1a Pdgfrb Plce1 Ptger3 Trpc1
Regulation of actin cytoskeleton 9,86E-04 9 F2r Fgfr3 Itga10 Itga7 Itga8 Myl9 Mylk Pdgfa Pdgfrb
Neuroactive ligand-receptor interaction 1,67E-03 10 Ednra F2r Glrb Grm3 Npy1r P2rx1 P2ry14 Ptger3 Pth1r S1pr3
Table 4.  Enriched signalling pathways in brain mural cell-enriched genes. KEGG pathways enriched in the 
260 brain mural cell-enriched genes. Statistical test’s p value, gene number and gene symbols are listed.
Figure 5. Protein interaction groups among brain mural cell-enriched genes. Proteins are represented with 
nodes and interactions between them are indicated with lines. The proteins are grouped according to their 
subcellular location (i.e cytoplasmic, membrane or extracellular). Proteins discussed in the text are indicated in red.
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and pathological conditions (Table 2) and platform bias. We propose, however, that genes identified by at least 
two approaches (260 genes) should be considered a conservative list of mural cell enriched transcripts. This list 
includes all known markers for PC but also a large number of genes that have not been previously linked to mural 
cell biology. The reader should also be aware that some mural cell-specific genes, which are only expressed at cer-
tain time points, might be missed in this list. In silico analysis of functional annotations and protein interaction 
networks pinpointed several significantly enriched pathways and protein interaction groups. To further validate 
the mural cell-enrichment, we selected two genes, Vtn and Ifitm1, for ISH validation. Despite different gene 
expression levels, both genes were shown to display a distinctly mural cell-specific pattern, with the majority in 
PC, although expression was detectable also in the VSMC of larger vessels. From the previously published single 
cell RNA-seq data (Figure S10)41, these two genes also showed higher expression in PC compared with other 
vascular cells. The functional roles of Vtn and Ifitm1 in PC await further analysis.
In conclusion, our analysis provides the most comprehensive, yet conservative, catalogue of mouse brain 
mural cell-enriched gene transcripts available to-date. It sheds new light on the molecular composition of the 
brain mural cells, including PC, and their molecular signaling pathways and interaction networks. Our analysis 
suggests numerous new PC markers, of which two were validated by ISH and/or IHC, and provides a rich source 
for new hypotheses to be tested about PC biology in health and disease.
Materials and Methods
Animals and animal experiments. The following wild type and transgenic animals of either sex were 
used: C57BL6/J, NG2-DsRed mice42, Pdgfrb-eGFP mice (Gensat.org. Line name: Tg(Pdgfrb-eGFP)JN169Gsat/
Mmucd). Animal experiment protocols were approved by the Stockholm North Ethical Committee on Animal 
Research (Permit number N16/12), the Uppsala Ethical Committee on Animal Research (Permit number: 
C224/12 and C225/12), and by the Cantonal Veterinary Office Zurich, Switzerland (ZH196/2014). All animal 
experiments were carried out in accordance with their guidelines.
Antibodies and immunohistochemistry. Mice under full anesthesia were euthanized by transcardial 
perfusion with Hanks buffered salt solution (HBSS, cat. # 14025092, GIBCO) containing 5 U/ml heparin fol-
lowed by 4% paraformaldehyde in phosphate buffered saline (PBS). Tissues were removed and postfixed in 4% 
paraformaldehyde for 4 hours at 4 °C. Immunohistochemistry was carried out on vibratome brain coronal sec-
tions (30 or 50 μ m) or on whole isolated retinas, as described9. Briefly, tissues were blocked and permeabilized 
in PBS containing 1% bovine serum albumin and 0.5% TritonX-100 in PBS overnight at 4 °C. Tissues were then 
incubated in primary antibody solution, washed, and subsequently incubated in secondary antibody solution. 
Each step was carried out overnight at 4 °C. Sections were mounted in Prolong Gold Antifade reagent with DAPI 
(cat. # P36931; Invitrogen). The following primary antibodies were used: mouse anti-human α -smooth muscle 
actin (Cy3 conjugated - cat. # C6198, FITC conjugated - cat. # F3777, Sigma Aldrich); rat anti-mouse CD31 (cat. 
# 553370, BD PharMingen); goat anti-CD13 (cat. # AF2335, R&D Systems); rabbit anti-vitronectin (cat. # GWB-
794F8F, GenWay); rat anti-mouse PDGFRβ (cat. # 14-1402, eBioscience). The fluorescently labelled secondary 
antibodies made in donkey or goat were purchased from Jackson ImmunoResearch.
Microvascular isolation. After cervical dislocation, the brains of three Pdgfrb-eGFP/NG2-DsRed mice at 
postnatal day 6 (P6) were dissected out and divided into two sagittal halves, of which one was processed for 
microvascular isolation and the other half was processed for FACS analysis (see further). The tissue was chopped 
into small pieces with scissors, and incubated with 0.5 mg/ml of collagenase 2 (Sigma, C6885) in Dulbecco’s 
Modified Eagle’s Medium (DMEM, Life Technologies) for 10 minutes at 37 °C. Afterwards, the suspension was 
neutralized with an equal amount of DMEM with 20% fetal bovine serum (FBS, Life technologies) to block 
collagenase activity. The digested tissue was then filtered over a 70 μ m mesh (BD Biosciences) to remove large 
undigested tissue pieces. After centrifugation, the pellet was resuspended in DMEM with 0.5 mg/ml heparin 
(Sigma) to prevent coagulation. The cell suspension was incubated with sheep anti-rat magnetic Dynabeads (Life 
technologies) bound to rat anti-mouse CD31 antibody (BD Pharmingen) for 30 minutes at room temperature to 
allow coating of microvascular fragments with beads. Afterwards, the microvascular fragments were separated 
from the rest of the tissue suspension with a DynaMag-2 magnet (Life technologies) and washed three times with 
DMEM containing 0.5 mg/ml of heparin. Finally, the microvascular fragments were lysed in RLT buffer and RNA 
was extracted with the Qiagen RNeasy micro prep kit according to the manufacturers protocol (Qiagen).
FACS. From a sagittal half of the brain, a single-cell suspension was obtained for FACS analysis in the follow-
ing way. The tissue was minced with scissors and incubated with DMEM containing 1 mg/ml of collagenase 2 at 
37 °C for 5 minutes with vigorous shaking. The suspension was then mechanically dissociated by pipetting up 
and down 10 times with a p1000 pipette, followed by another incubation for 5 minutes at 37 °C. Afterwards, the 
collagenase 2 was neutralized in the suspension by addition of an equal volume of DMEM with 20% FBS. The cells 
were filtered over a 70 μ m mesh and centrifuged to obtain a pellet, which was resuspended in DMEM containing 
2% FBS. Cells positive for eGFP and DsRed were obtained by FACS using a BD FACSAria III (100 μ m nozzle 
size, 20 psi sheet pressure, 488 nm and 561 nm excitation lasers for eGFP and DsRed, respectively) at the BioVis 
core facility at the Department of Immunology, Genetics and Pathology (IGP), Uppsala University. Cells were 
sorted straight into RLT lysis buffer and RNA was extracted with the Qiagen RNeasy micro prep kit according to 
the manufacturers protocol (Qiagen). The scatter plots were generated using FlowJo v10.0.8r1 (FlowJo, LCC) to 
illustrate the intensity of eGFP and DsRed channel of analyzed cells.
RNA-seq library construction. RNA integrity and concentration of the FACS sorted cells and the isolated 
microvasculature was checked with the Agilent RNA 6000 pico kit and the Agilent 2100 Bioanalyzer (Agilent 
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Biotechnologies). For conversion of the RNA to a cDNA library for Illumina sequencing, the SMARTer® Stranded 
Total RNA Sample Prep Kit - Low Input Mammalian kit from Clontech was used according to the manufacturer’s 
protocol. The total RNA was depleted from rRNA and tRNA’s with the RiboGone- Mammalian kit (Clontech) 
prior to library construction. The samples were sequenced on an Illumina HiSeq 2500 sequencer at the SNP&SEQ 
sequencing facility (Science for Life laboratory (SciLifeLab), Uppsala sequencing node).
In situ RNA hybridization. In situ RNA hybridization was performed using RNAscope technol-
ogy (Advanced Cell Diagnostics) following the manufacturer’s protocol with minor modifications. Briefly, 
fresh-frozen brains were cut into 16 μ m sagittal sections and mounted on SuperFrost Plus glass slides. After dehy-
dration, slides were subjected to RNAscope Multiplex Fluorescent Assay. First, slides were incubated in Pretreat 
4 for 20 min at RT. After that, RNAscope probes were hybridized for 2 h at 40 °C and the remainder of the assay 
protocol was implemented. The fluorescent signal emanating from RNA probes was visualized and captured 
using a Leica TCS SP8 confocal microscope (Leica Microsystems). All in situ hybridization images presented are 
2D maximum intensity projections of ~3 μ m z-stacks. According to the Advanced Cell Diagnostics, each mRNA 
molecule hybridized to a probe appears as a separate small fluorescent dot.
RNA-seq data analysis. The sequencing libraries for three microvascular samples and three FACS sorted 
cells were pooled after indexing and ran on a single lane (paired-end sequencing, 125 bp reads, high-output 
mode). In each sample, over 25 million pair-end reads were sequenced. The reads were aligned to the Ensembl 
mouse gene assembly (NCBIM37) using Tophat2 software (version 2.0.4)74. The duplicated reads were removed 
using the picard tool (version 1.92, http://broadinstitute.github.io/picard/). To identify the genes significantly 
enriched in the PC samples as compared with microvascular samples, statistical tests were performed using the 
Cufflinks tool (version 2.2.1)75.
Meta-analysis of mural cell-enriched genes. The potential mural cell-enriched genes were collected 
from four published studies, and also included the results from our current RNA-seq study on FACS sorted brain 
mural cells.
From our previously published Affymetrix microarray study using pdgfbret/ret mutant mice (NCBI GEO acces-
sion number GSE15892), the four pdgfbret/ret brain vascular samples were compared with controls. The raw array 
data were normalized using Bioconductor (www.bioconductor.org) GCRMA package (version 2.32.0) and the 
probe sets which had signals defined as present in at least half of the arrays were selected for further analysis. 
Significance Analysis of Microarrays (SAM) method (Bioconductor Siggenes package, version 1.34.0) was applied 
to identify the significantly differentially expressed genes. The affymetrix probe sets were mapped to the NCBI 
Entrez Gene using the Biocondcutor annotation package (mouse4302.db, version 2.9.0). From the analysis, 453 
genes which are more than two fold down-regulated in the pdgfbret/ret as compared with controls were identified 
(False Discovery Rate < 0.05).
As described previously39, 142 mouse UniGene Clusters were reported as more than two fold down-regulated 
in both Pdgfb and Pdgfrb mutant brain microvessels, compared with controls. They were mapped to 135 NCBI 
Entrez Genes and were used in the comparisons.
From the BBB transcriptome data performed by Daneman et al.40, two lists of brain PC and brain 
endothelial-enriched genes were reported. The affymetrix probe sets were mapped to the NCBI Entrez Gene using 
the Biocondcutor annotation package (mouse4302.db, version 2.9.0). In total, there are 175 brain PC-enriched 
genes and 1631 brain endothelial-enriched genes.
In the recently published brain single cell RNA-seq analysis, 155 genes were reported to be enriched in the 
brain mural cells. They were mapped to the NCBI Entrez Gene using gene symbol.
To compare the five data sets and visualize the result, we used the R code which we posted in the bioconductor 
community previously (https://support.bioconductor.org/p/19693/).
Pathway analysis. Pathway analysis was performed using KEGGprofile package (version 1.2.0) in R software 
(www.r-project.org). It carries out Hypergenometic tests to identify the KEGG pathways that are over-represented 
among the 260 identified mural cell-enriched genes, and p < 0.01 was considered statistically significant and 
pathways with at least nine mural cell-enriched genes were selected.
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